BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — CareDx Inc. (CDNA) on Wednesday reported a loss of $10.4 million in its first quarter.
On a per-share basis, the Brisbane, California-based company said it had a loss of 19 cents. Earnings, adjusted for stock option expense and non-recurring costs, were 9 cents per share.
The molecular diagnostics company posted revenue of $84.7 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $84.9 million.
CareDx expects full-year revenue in the range of $365 million to $375 million.
CareDx shares have fallen 21% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $16.88, more than doubling in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CDNA at https://www.zacks.com/ap/CDNA
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.